Peptides

Blocker of Kv2 channels

Peptide Ac-GQVGRQLAIIGDDINR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-GQVGRQLAIIGDDINR-NH2 include the following: A novel cell-penetrating peptide to facilitate intercellular transport of fused proteins Y Shen, P Nagpal , JG Hay , H Sauthoff - Journal of controlled release, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365914003903 A New Assay Based on Fluorescence Resonance Energy Transfer to Determine the Binding Affinity of Bcl-xL Inhibitors Y Feng , X Shen , K Chen, H Jiang - Bioscience , 2008 - academic.oup.comhttps://academic.oup.com/bbb/article-abstract/72/7/1936/5941175 An inhibitor of Bcl-2 family proteins induces regression of solid tumours T Oltersdorf, SW Elmore, AR Shoemaker - Nature, 2005 - nature.comhttps://www.nature.com/articles/nature03579 Supramolecular antagonists promote mitochondrial dysfunction M Li, Y Song, N Song, G Wu, H Zhou , J Long - Nano Letters, 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.nanolett.1c01469 Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells JL Wang, ZJ Zhang, S Choksi , S Shan, Z Lu, CM Croce - Cancer research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/6/1498/507208 Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells JL Wang, D Liu, ZJ Zhang, S Shan - Proceedings of the , 2000 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.97.13.7124 Identification of novel small molecule Beclin 1 mimetics activating autophagy J Yu, L Lan , SJ Lewin, SA Rogers, A Roy, X Wu - Oncotarget, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584254/ Kröhnke pyridines: Rapid and facile access to Mcl-1 inhibitors IL Conlon , D Van Eker, S Abdelmalak - Bioorganic & medicinal , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960894X18302439 Synthesis and helical structure of lactam bridged BH3 peptides derived from pro-apoptotic Bcl-2 family proteins B Yang, D Liu, Z Huang - Bioorganic & medicinal chemistry letters, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0960894X04000617 Structural biology of the Bcl-2 family of proteins AM Petros, ET Olejniczak , SW Fesik - Biochimica et Biophysica Acta (BBAhttps://www.sciencedirect.com/science/article/pii/S0167488903001757

H-Asp-Gly-OH is a peptide hormone that belongs to the group of hydroxylated aspartic acid. This peptide hormone has been shown to be a lymphocyte transformation factor in vitro and stimulates the production of collagen and other proteins. It has also been shown to have anticarcinogenic effects on bone cancer cells, which may be due to its ability to induce apoptosis. H-Asp-Gly-OH has a neutral pH and forms stable complexes with metal ions, such as copper and zinc, which are important for a variety of biological functions.

Peptide H-QGVAEAAGK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QGVAEAAGK^-OH include the following: Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's disease H Kobayashi, R Kruacaˆger , K Markopoulou, Z Wszolek - Brain, 2003 - academic.oup.comhttps://academic.oup.com/brain/article-abstract/126/1/32/299345

Peptide H-AAHTEDINACTLTTSPR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AAHTEDINACTLTTSPR-OH include the following: Data-independent acquisition-based SWATH-MS for quantitative proteomics: a tutorial C Ludwig , L Gillet , G Rosenberger , S Amon - Molecular systems , 2018 - embopress.orghttps://www.embopress.org/doi/abs/10.15252/msb.20178126

Cyclo(-Met-Pro) is a synthetic antioxidant that inhibits the proliferation of cancer cells. Cyclo(-Met-Pro) binds to the reactive oxygen species (ROS), such as hydroxyl, alkoxy, and peroxyl radicals, in the cell and prevents them from damaging DNA. Cyclo(-Met-Pro) also inhibits the generation of ROS by reacting with metal ions, such as iron and copper. This compound has been shown to have an effect on human cells by inhibiting the proliferation of cancer cells. Cyclo(-Met-Pro) is synthesized by reacting methylamine with cyclopentadiene in sodium hydroxide solution or hydroxide solution. The synthesis can be monitored using spectrometry analyses.

A synthetic peptide for use as a blocking control in assays to test for specificity of SMUG1 antibody, catalog no. 70R-2095

F1324: potent BCL6 inhibitor, IC50=1nM, binding t1/2=441s, strongly inhibits BCL6 PPI.

Peptide H-EMLIKPKEL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EMLIKPKEL-OH include the following: Binding stability of peptides on major histocompatibility complex class I proteins: role of entropy and dynamics A Gul, B Erman - Physical Biology, 2018 - iopscience.iop.orghttps://iopscience.iop.org/article/10.1088/1478-3975/aa93b8/meta

A synthetic peptide for use as a blocking control in assays to test for specificity of PPM1M antibody, catalog no. 70R-3594

A synthetic peptide for use as a blocking control in assays to test for specificity of FLJ37543 antibody, catalog no. 70R-3454

Peptide H-LTAYHVSTAPTGSWF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LTAYHVSTAPTGSWF-OH include the following: Supplementary figures Kessler & Shafer ID Sample - researchgate.nethttps://www.researchgate.net/profile/Camille-Kessler/publication/373137307_Supplementary_tables_and_figures/data/659c1c930bb2c7472b3ca999/V3-Supplementary.pdf

Peptide H-SLLTEVETPIRNEWGSRSNDSSD-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLLTEVETPIRNEWGSRSNDSSD-OH include the following: Towards improved and broadly protective influenza vaccines: Focus on delivery systems, routes of administration and animal models Y Bhide - 2018 - research.rug.nlhttps://research.rug.nl/en/publications/towards-improved-and-broadly-protective-influenza-vaccines-focus- pter 2 WD Yoshita Bhide, I Gribonika, D Voshart - Diseases , 2018 - research.rug.nlhttps://research.rug.nl/files/64971290/Complete_thesis.pdf#page=32 Porous nanoparticles with self-adjuvanting M2e-fusion protein and recombinant hemagglutinin provide strong and broadly protective immunity against influenza virus V Bernasconi, B Bernocchi, L Ye , MQ Le - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.02060/full Design of a Universal Influenza A Vaccine Candidate Based on M2e. FliC; Immunoinformatics Analysis, Protein Modeling, and Its Expression in Escherichia SMJ Kolour , F Behzadian, B Farahmand - Jundishapur Journal of , 2018 - brieflands.comhttps://brieflands.com/articles/jjm-66592 In contrast to conventional inactivated influenza vaccines, 4xM2e. HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A SM Ebrahimi, M Dabaghian, M Tebianian , MHZ Jazi - Virology, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682212002103 Synthetic long peptide influenza vaccine containing conserved T and B cell epitopes reduces viral load in lungs of mice and ferrets SK Rosendahl Huber, MGM Camps, RHJ Jacobi - PloS one, 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0127969 Antigen-presenting, self-assembled protein nanobarrels as an adjuvant-free vaccine platform against influenza virus S Kang, Y Kim , Y Shin, JJ Song, S Jon - ACS nano, 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.1c04078 IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine MB Appaiahgari , S Vrati - Expert review of vaccines, 2010 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1586/erv.10.139 Generation of Broad Protection against Influenza with Di-Tyrosine-Cross-Linked M2e Nanoclusters LR Wilks, G Joshi , N Rychener, HS Gill - ACS Infectious Diseases, 2024 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsinfecdis.3c00429 Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge L Deng, JR Kim, TZ Chang , H Zhang, T Mohan - Virology, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S004268221730171X A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus DG Eliasson, A Helgeby, K Schön, C Nygren - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X1100483X< Valentina Bernasconi1, Beatrice Bernocchi2, Liang Ye3, Minh Quan Lacaª2, Ajibola Omokanye1, Rodolphe Carpentier2, Karin Schön1, Xavier Saelens4, 5, Peter C Chevalier - Innovative Therapeutic and Vaccine Approaches , 2020 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=-YLhDwAAQBAJ&oi=fnd&pg=PA20&dq=(%22H-SLLTEVETPIRNEWGSRSNDSSD-OH%22+OR+%22SLLTEVETPIRNEWGSRSNDSSD%22+OR+%22NH2-Ser-Leu-Leu-Thr-Glu-Val-Glu-Thr-Pro-Ile-Arg-Asn-Glu-Trp-Gly-Ser-Arg-Ser-Asn-Asp-Ser-Ser-Asp-OH%22)+AND+peptide&ots=07ycxq48Vr&sig=m3b4Yg-JbFMxJQwAZzrIn35RORA Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes BR Park, J Subbiah , KH Kim , YM Kwon, J Oh, MC Kim - Virology, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682221002439 Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and AA Zykova, EA Blokhina, LA Stepanova, MA Shuklina - Molecules, 2023 - mdpi.comhttps://www.mdpi.com/1420-3049/28/18/6441 Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus AA Rumyantsev, Z Zhang, Q Gao, N Moretti, N Brown - Virology, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682209006576

H-LLYNCCYHV-OH is a custom research peptide; min purity 95%, TFA salt. For different specs please use the Peptide Quote Tool

A synthetic peptide for use as a blocking control in assays to test for specificity of LEFTY1 antibody, catalog no. 70R-6222

Ac-Arg-Gly-Lys(Ac)-MCA is a peptide that is used as a histone deacetylase substrate. It is an enzyme substrate in the histone deacetylase reaction and it has been shown to inhibit the growth of many bacterial strains. Ac-Arg-Gly-Lys(Ac)-MCA has been shown to inhibit the growth of Staphylococcus aureus, Bacillus subtilis, and Pseudomonas aeruginosa.

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.